Hans Ulrich Esslinger
Affiliation: Abbott Laboratories
- Effects of PEG-hirudin in clotting parameters and platelet function and its interaction with aspirin in healthy volunteersHans Ulrich Esslinger
Abbott GmbH and Co KG, Ludwigshafen, Germany
Clin Appl Thromb Hemost 9:79-88. 2003..None of the clotting parameters or platelet function tests correlated with the prolongation of the bleeding time...
- Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavirCheri E Klein
Department of Clinical Pharmacokinetics and Pharmacodynamics, Abbott Laboratories Department R4PK, Bldg AP13A, 100 Abbott Park, Abbott Park, IL 60064 6140, USA
J Clin Pharmacol 48:553-62. 2008..In contrast, atazanavir bioavailability was decreased by 48% to 62% when coadministered with ritonavir and either omeprazole or ranitidine...
- Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysisKatrin Annett Pöschel
Department of Internal Medicine IV, Friedrich Schiller University, Jena, Germany
Kidney Int 65:666-74. 2004....
- The effects of multiple doses of fenofibrate on the pharmacokinetics of pravastatin and its 3alpha-hydroxy isomeric metaboliteLinda E Gustavson
Department of Clinical Pharmacokinetics, Abbott Laboratories, Deptartment R4PK, Building AP13A, 100 Abbott Park Road, Abbott Park, IL 60064 6104, USA
J Clin Pharmacol 45:947-53. 2005..Pravastatin and 3alpha-hydroxy-iso-pravastatin systemic exposures were not statistically significantly different following the 1st and 10th doses of fenofibrate...